First Quarter 2025 Earnings Presentation Q1'25 Earnings 4/29/25 2 First Quarter 2025 Overview April 29, 2025 Safe Harbor & Non-GAAP Measures Except for historical information contained herein, the matters set forth in this presentation are forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those forward-looking statements. Potential risks and uncertainties include such factors as the Company's ability to successfully implement it ...

Financial Data and Key Metrics Changes - Revenue from continuing operations grew 23.1% year over year to RMB9.39 billion, while total revenue achieved RMB9.65 billion, representing a 21% year over year growth [9] - Adjusted non-IFRS net profit grew 40% year over year to RMB2.68 billion, with a record backlog for continuing operations of RMB52.33 billion, growing 47.1% year over year [9][10] - Adjusted IFRS gross profit margin reached 41.9%, with net profit attributable to the owners of the company increasing by 89.1% year over year [26][27] Business Line Data and Key Metrics Changes - Wuxi Chemistry's CRDMO business revenue grew 32.9% year over year to RMB7.39 billion, with adjusted non-IFRS gross profit margin improving 4.2 percentage points year over year to 47.5% [11][12] - Small molecule DNM business revenue grew 13.8% year over year to RMB3.85 billion, with both Changzhou and Taishin API manufacturing sites passing FDA inspections [13] - Tides business achieved RMB2.24 billion revenue in the first quarter, representing a strong growth of 187.6% year over year [14] Market Data and Key Metrics Changes - Revenue from the U.S. market grew 28.4% year over year, while revenue from Europe grew 26.2% year over year; however, China showed a slight decline [10] - Revenue generated from clinical CRO and SMO business was down 2.2% year over year to RMB0.61 billion, attributed to market price impact [21][22] Company Strategy and Development Direction - The company will continue to focus on the CRDMO business model with an emphasis on operational efficiency and exceptional services [29] - Full year guidance is maintained, expecting revenue from continuing operations to resume double-digit growth of 10% to 15% year over year, targeting total revenue of RMB41.5 billion to RMB43 billion [30] - The company plans to accelerate global D and M capacity expansion, with CapEx expected to reach RMB7 billion to RMB8 billion [30] Management Comments on Operating Environment and Future Outlook - Management acknowledges the dynamic and complex global environment, emphasizing the need for operational resilience [29] - Despite external uncertainties, the company maintains confidence in its business model and operational capabilities [30] - The management team is committed to enhancing shareholder value through dividends and share repurchase plans [31][32] Other Important Information - The company plans to maintain a 30% annual cash dividend payout ratio of net profit, totaling approximately RMB2.8 billion, along with a one-time special cash dividend of RMB1 billion [31] - The company will repurchase and cancel RMB1 billion worth of A shares when appropriate in 2025 [32] Q&A Session Summary Question: What are the key drivers behind the robust growth in Tides? - The growth is attributed to both strong demand and capacity ramping up from a low base last year [37] Question: How does the company view the impact of tariffs on business segments? - Tariffs are seen as a systemic challenge, with less than 10% of total revenue coming from exports to the U.S. [45][46] Question: What is the expected CapEx distribution for 2025? - CapEx will focus on expanding new modality and small molecule capacities in China, Singapore, and the U.S., with over 70% allocated to D and M manufacturing capacity expansion [54] Question: How does the company plan to address pricing pressures in testing and biology segments? - The company aims to focus on contracts with higher margins and differentiation strategies to improve margins gradually [68] Question: What is the expected revenue contribution from late-stage D and M projects? - Specific numbers are difficult to provide, but the company expects sustained growth from its CRDMO business model [71]

Investment Rating - The report does not explicitly provide an investment rating for the sectors discussed Core Insights - The report highlights the impact of increased US tariffs on various sectors including appliances, autos, industrial tech, and solar companies, with management expressing concerns over supply chain disruptions and capital allocation strategies China Consumer Durables - Companies derive an average of 35% of revenues from China exports and 7% from exports to the US [5] - Production is shifting to overseas factories, with some companies receiving more orders from US clients as they seek to restock before the tariff reprieve period ends [6] - There is low visibility on price re-negotiation, with companies cautious about raising prices due to market share concerns [6] - Ex-US demand remains stable, particularly in Europe, which is expected to absorb US capacity [6] - CAPEX visibility is low, with Mexico considered a safer investment location due to its free trade agreement with the US [6] China Autos - Companies derive 6%-26% of total revenue from China exports and 0%-10% from exports to the US [7] - Management believes US-China trade tensions have softened recently, with expectations of higher exports to Europe due to ongoing negotiations [7] - Auto suppliers report no order cancellations and are negotiating new prices, with some passing on the full tariff burden to customers [8][10] China Industrial Tech - Companies derive 15%-45% of total revenue from exports and 2%-20% from exports to the US [11] - Orders paused initially in early April but returned to normal by the second week, with some customers continuing their overseas construction plans despite tariff uncertainties [11] - Most companies have signed FOB contracts, meaning customers bear the tariff costs [11] - Companies are maintaining existing capacity expansion plans, with some pausing expansion until tariff policies are clearer [12] China Solar - Companies involved in solar exports have 0%-15% direct exports to the US and 35%-55% to other countries [17][18] - One company has stopped shipping ESS products to the US due to high tariffs, while others are expanding inverter capacity overseas [19] - Softening demand in the US is a key challenge, with concerns over potential price hikes dampening downstream demand [20] - Companies are considering scaling back US exposure if operational risks outweigh profitability compared to other regions [20]

Core Viewpoint - Lumibird Group reported a consolidated revenue growth of 12.4% in Q1 2025, reaching €49.4 million, driven by strong performance in both the Photonics and Medical divisions [1][3]. Revenue Summary - Consolidated revenues for Q1 2025 were €49.4 million, an increase of 12.4% compared to €43.9 million in Q1 2024, with a constant exchange rate growth of 11.7% [3]. - The Photonics division generated €23.9 million, up 15.8% from €20.6 million in Q1 2024, with a constant exchange rate growth of 15.1% [3][4]. - The Medical division achieved revenues of €25.5 million, reflecting a growth of 9.4% from €23.3 million in Q1 2024, with a constant exchange rate growth of 8.6% [3][6]. Division Performance - The Defence/Space business within the Photonics division saw sales rise by 37.8% to €10.5 million, attributed to multi-year contracts and order book deliveries [4]. - Industrial and Scientific sales increased by 7.0% to €5.9 million, including €0.5 million from the Continuum range acquired in October 2024 [5]. - Medtech sales slightly declined by 2.3% to €3.9 million, impacted by the timing of deliveries throughout 2025 [5]. Geographical Breakdown - EMEA revenues for Photonics were €13.8 million, up 16.2%, while Medical revenues were €7.6 million, down 6.0% [7]. - In the Americas, Photonics revenues increased by 54.1% to €4.5 million, and Medical revenues rose by 2.1% to €6.6 million [7]. - Asia-Pacific Photonics revenues decreased by 17.5% to €2.9 million, while Medical revenues increased by 29.1% to €8.1 million [7]. Future Outlook - Lumibird anticipates continued business expansion driven by growth in Defence/Space and Medical markets, with no significant impact expected from increased customs barriers [10][11].

Financial Data and Key Metrics Changes - InMode generated total revenue of $77.9 million in Q1 2025, a decrease of 3% compared to Q1 2024 [8] - GAAP gross margin was 78% in Q1 2025, down from 80% in Q1 2024 [8] - Non-GAAP diluted earnings per share were $0.31, compared to $0.32 in Q1 2024 [12] - The company ended the quarter with cash and cash equivalents of $512.9 million [12] Business Line Data and Key Metrics Changes - Minimally invasive platforms accounted for 87% of total revenues in Q1 2025 [9] - Sales and marketing expenses decreased slightly to $39.7 million in Q1 2025 from $39.8 million in Q1 2024 [11] Market Data and Key Metrics Changes - International sales accounted for $38 million or 49% of total sales, a 1% increase compared to Q1 2024 [9] - Europe was the largest revenue contributor from outside the U.S., achieving record sales [10] Company Strategy and Development Direction - The company plans to unveil a new platform for the wellness market later this year, reflecting its strategy to diversify offerings [6] - InMode has committed to not reducing its workforce and aims to lead the industry during the market rebound [6] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing macroeconomic uncertainty and soft consumer demand affecting the medical aesthetic market [4] - The company anticipates a potential reduction in operating margins by 4% to 5% due to market pressures and U.S. tariffs [13] - Management remains optimistic about a market recovery, contingent on Q2 performance [30] Other Important Information - InMode returned over $412 million to shareholders through share repurchases over the past twelve months, representing approximately 27% of total capital [7] - The company has not yet hired a new President for the U.S. and is currently led by the acting President [66] Q&A Session Summary Question: Follow-up on product mix dynamics - Management indicated that the slowdown began in mid-2023 due to rising interest rates and decreased consumer confidence, impacting capital equipment purchases [20][21] Question: Guidance for Q2 and market trends - Management expects Q2 to be stronger than Q1, but if results do not improve, guidance may need to be lowered [31][40] Question: Impact of tariffs on guidance - Tariffs are expected to impact gross margins by approximately 2% to 3% if they remain at 10% [57][79] Question: Updates on operating expenses - The company plans to maintain its investment in sales and marketing despite macro challenges, which may impact profitability [65] Question: Pricing strategy in the current market - Management decided not to raise prices due to the current market conditions, despite tariff impacts [70][90] Question: Performance in Europe compared to the U.S. - Europe has shown better performance due to management changes and pricing strategies, although credit conditions are tightening [83]

Investment Rating - The industry view is rated as Attractive, with a preference for gold, cement, building materials, and steel for 2Q25 [7]. Core Insights - Demand in the materials sector showed signs of recovery in 1Q25, but the outlook for 2Q25 is uncertain due to tariff concerns. Domestic excavator sales increased by 38% YoY, and orders from cathode producers rose by 20% due to strong demand from electric vehicles (EV) and energy storage [2]. - The report anticipates that metals-related stocks may outperform in 2H25 as further stimulus is expected [1][6]. - The tariff impact is projected to weigh heavily on the materials space, with a forecasted GDP growth reduction of 30 basis points to 4.2% for 2025 due to tariff shocks and domestic demand impacts [2][18]. Summary by Sections Gold - Gold is identified as the top pick within commodities, supported by ongoing central bank buying and rising ETF inflows. Lower Treasury yields are expected to enhance gold's macro backdrop. Preferred stocks include Zhaojin (1818.HK) and Zijin Mining (2899.HK, 601899.SS) [3]. Cement and Steel - Cement supply-side controls were announced in November 2024, leading to a focus on profitability rather than price wars. The report expects a significant increase in gross profit per ton due to lower coal prices and higher cement prices. For steel, a production cut of 30 million tons and an export cut of 15-20 million tons are anticipated in 2025. Preferred stocks include Anhui Conch (0914.HK, 600585.SS), CNBM (3323.HK), and Baosteel (600019.SS) [4]. Copper and Aluminum - In 2H25, copper and aluminum are expected to outperform due to continued demand from grid and EV-related green infrastructure. Additional fiscal stimulus could further support demand. Preferred stocks include Zijin (2899.HK, 601899.SS), CMOC (3993.HK, 603993.SS), and Hongqiao (1378.HK) [5]. Tariff Impact - The report highlights that the current cumulative US tariffs could have a more significant growth drag than in 2018-19, with expectations of trade talks to lower tariffs to 34% by year-end. The tariff shocks are expected to impact both trade channels and domestic demand [17][18].

Investment Rating - The report assigns a positive outlook on the Japan Electronics sector, indicating that sector stocks are attractive following an average decline of approximately 10% over the past month [1]. Core Insights - The report anticipates that US tariffs will be revised before causing a recession, with minimal to moderate impact on Japan's industrial and consumer electronics sectors compared to other export industries [1][2]. - Company-specific catalysts such as restructuring and buybacks are highlighted as potential growth drivers [1]. - The focus is on upcoming results from Hitachi and NEC, which are expected to be less affected by tariffs, while long-term growth prospects are emphasized for Mitsubishi Electric, Panasonic, and Fujitsu [1]. Summary by Sections Tariff Impact - The report suggests that tariffs could depress the sector's operating profit (OP) by 21% in gross terms for FY3/26, with varying impacts across companies: Sharp (174%), Yamaha (67%), Hitachi (5%), and Fujitsu (7%) [4][6]. - In a best-case scenario, the average impact on OP across the sector is estimated to be 9% [4]. Company-Specific Analysis - **Sony**: Expected to face the largest impact due to tariffs on PS5 sales, with a significant portion of production in China [8][9]. - **Panasonic**: Anticipated to be heavily affected due to its US sales of white goods and batteries, although some operations may mitigate tariff impacts [10][11]. - **Mitsubishi Electric**: Projected to experience a major impact primarily on air conditioner sales, with 17% of sales coming from North America [12]. - **Hitachi**: Expected to have a minimal impact with a 5% reduction in OP, potentially decreasing to 3% with strategic responses [15]. - **NEC**: Anticipated to be largely unaffected due to its low US sales weighting [16]. - **Casio and Yamaha**: Projected to see significant profit reductions of 47% and 67% respectively, as both companies are in a post-restructuring phase [17][19].

Financial Performance - For Q1 2025, the company reported net sales of $576.8 million, a decrease of 2% compared to $590.2 million in Q1 2024 [3][8] - Gross margin for Q1 2025 was 33.2%, down from 34.3% in Q1 2024, but improved by 70 basis points from Q4 2024 [4][8] - Operating income for Q1 2025 was $113.0 million, compared to $129.3 million in Q1 2024 [6][8] - Net income for Q1 2025 was $94.9 million, down from $108.2 million in Q1 2024, with earnings per diluted share at $0.42, a decrease of 11% from $0.47 in Q1 2024 [8][9] Market Conditions - Global light vehicle production increased by approximately 1% year-over-year but decreased by 3% quarter-over-quarter in primary markets [3] - The company experienced a shortfall of expected sales of approximately $25 - $30 million due to a weaker trim-mix in light vehicle production [3] Operating Expenses - Operating expenses rose by 8% to $78.7 million in Q1 2025, influenced by severance expenses of $2.9 million and one-time merger-related costs of $0.9 million [5][8] - Core operating expense growth was less than 3% for the quarter, excluding severance and merger-related expenses [5] Future Guidance - The company revised its revenue guidance for 2025 to $2.10 - $2.20 billion, down from the previous estimate of $2.40 - $2.45 billion, due to tariff impacts [18] - Light vehicle production in primary markets is expected to decline approximately 5% in 2025 compared to 2024, with a forecasted decrease of about 11% in the last three quarters of 2025 [15][16] Share Repurchases - During Q1 2025, the company repurchased 3.1 million shares at an average price of $24.52 per share, with approximately 6.3 million shares remaining available for repurchase [12]

Financial Data and Key Metrics Changes - The company reported Q1 2025 revenue of $132 million, at the high end of the guided range, with EPS of $0.18, also at the midpoint of guidance [11][18] - Gross margins for Q1 were 48.7%, down 450 basis points year-over-year, primarily due to a supply agreement impacting margins and unfavorable customer mix [18] - Cash from operations exceeded the high end of the guided range, driven by higher than expected customer prepayments [20][21] Business Line Data and Key Metrics Changes - MedTech and Specialty Audio revenue was $60 million, slightly up year-over-year but seasonally down from Q4 [11][18] - Precision Device segment revenues were $73 million, flat compared to Q4, with gross margins at 35.7%, flat year-over-year [12][18] - The company expects year-over-year revenue growth to accelerate in Q2 2025, driven by strong demand in MedTech and Specialty Audio [12][16] Market Data and Key Metrics Changes - The company estimates that less than 5% of revenue is subject to current tariffs, with less than 3% of cost of goods sold impacted [6][8] - Inventory levels at distributors are normalizing, leading to increased order activity, particularly in the industrial market [33][52] Company Strategy and Development Direction - The company is focused on growth in 2025, with expectations for year-over-year revenue growth and strong cash generation [15][24] - The management highlighted the importance of partnerships with customers to drive innovation and performance enhancements in products [12][16] - The company plans to explore acquisition opportunities and maintain manageable debt levels while investing in capacity expansion [14][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to grow despite the current tariff environment, citing essential nature of products in MedTech and defense sectors [4][10] - The company is monitoring the macroeconomic environment closely, particularly in the industrial market, but currently sees no significant impact on demand [10][33] - Management anticipates a stronger second half of 2025, driven by increasing order activity and a growing backlog [39][40] Other Important Information - The company repurchased $5 million in shares and reduced debt by $15 million during Q1 [14][21] - The company expects capital spending to be 5% of revenues as it increases investments in capacity expansion related to the specialty film line [23] Q&A Session Summary Question: Can you discuss overall end market customer exposure and outlook? - Management noted no change in demand and higher expectations for Q2 compared to the previous quarter, emphasizing the essential nature of products in MedTech and defense [30][32] Question: Any updates on the $75 million capacitor order for the energy market? - Management confirmed a substantial prepayment received in Q1, indicating strong customer commitment and no expected impact on delivery starting in 2026 [35] Question: Can you provide insights on gross margin trajectory for Q2 and Q4? - Management expects significant sequential improvement in gross margins, driven by increased capacity utilization and better customer mix [38][39] Question: Are there opportunities for market share gain from competitors? - Management acknowledged receiving inquiries from customers considering switching suppliers due to tariff impacts, particularly in the industrial space [45][46] Question: Can you comment on bookings and receivables? - Management reported strong bookings trends and noted that receivables were up due to timing of customer payments, with no collection issues [49][55]

Financial Data and Key Metrics Changes - Brunswick's first-quarter results exceeded expectations despite a challenging macro environment, with a notable $160 million improvement in free cash flow compared to Q1 2024, marking the second-best first-quarter cash flow on record [9][10] - Net sales decreased by 11% year-over-year, with adjusted operating margins at 6%, resulting in an adjusted EPS of $0.56 [27][28] - The updated adjusted EPS guidance for 2025 is now between $2.50 and $4.00 per share, reflecting significant uncertainty due to trade policy and macroeconomic conditions [22][36] Business Line Data and Key Metrics Changes - The propulsion business experienced a 16% decrease in sales primarily due to pipeline management and lower wholesale shipments, while the aftermarket engine parts and accessories business saw a 3% decrease in sales but a 7% increase in adjusted operating earnings [29][30] - The boat business reported a 13% decrease in sales, attributed to cautious wholesale ordering patterns, although Freedom Boat Club continued to expand globally with steady membership growth [31][14] - Navico Group's sales were flat year-over-year, with strong aftermarket sales offsetting reduced OEM orders [12][30] Market Data and Key Metrics Changes - The US main powerboat industry retail was down modestly in Q1, with Brunswick's performance primarily affected by declines in the value segment [18] - Outboard engine industry retail units declined by 6%, with Mercury's performance slightly lower due to registration calendarization [21] - US weeks on hand decreased to 35.6%, indicating a reduction in inventory levels compared to Q1 2024 [21] Company Strategy and Development Direction - Brunswick is considering streamlining its entry-level product offerings due to observed weakness in that segment, focusing on higher-margin products and growth opportunities [7][81] - The company is actively working on mitigating tariff impacts through supply chain adjustments, pricing strategies, and classification of components to minimize exposure [16][110] - Brunswick aims to maintain a strong focus on cash generation, with a target of $350 million in free cash flow for the year [36] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the retail environment, noting stable dealer sentiment despite consumer volatility [17] - The uncertain tariff environment and macroeconomic conditions are expected to impact consumer spending, with potential volume pressures anticipated in the near term [14][24] - Management remains confident in the resilience of premium brands and their ability to navigate current challenges, with expectations for a flat US retail boat market in 2025 [37][92] Other Important Information - Brunswick launched several new products at the Miami Boat Show, including the SIMRAD NSS four multifunction display and the Flight Series 5 [38][39] - The company received multiple awards for its products and workplace culture, including recognition for being one of America's most trustworthy companies [41][42] Q&A Session Summary Question: Can you help us understand the guidance update for 2025? - Management indicated that the high end of the guidance range assumes a moderation in the tariff environment and better-than-expected mitigation efforts, while the low end reflects continued tariff pressures and volume declines [48][50] Question: What is the anticipated gross number for tariff mitigation? - Management stated that while it's difficult to provide an exact number, the gross impact is likely less than double the net impact due to various factors affecting timing and payment [60] Question: What are the plans to streamline entry-level boats? - Management confirmed that they are reducing the number of models in the entry-level category, focusing on higher-margin products and optimizing manufacturing [81][84] Question: How is the capital market volatility affecting consumer behavior? - Management noted that while there is some concern regarding capital market volatility, premium brands have shown resilience, and retail financing rates remain stable [92][125] Question: What are the mitigation actions against tariffs? - Management highlighted pricing strategies, supply chain migration, and component classification as key mitigation actions, with a significant reduction in dependency on China expected [108][111]